Every record from Medutest · page 10
Fast turnaround and the widest compound acceptance, at unit mass resolution rather than high resolution. Measured offset against the reference laboratory is +0.065 pp on 517 paired lots. Full laboratory profile →
| Report | Compound | Supplier | Lot | Quarter | Purity % | Water % | Recovery % | Provenance | Flags | Result |
|---|---|---|---|---|---|---|---|---|---|---|
| AX-2025-020075 | Semaglutide | ERP | ERP-2509-A8587 | 2025-Q4 | 98.50 | 6.42 | — | Supplier-supplied | 0 | PASS |
| AX-2025-019340 | Liraglutide | TFC | TFC-2510-C7425 | 2025-Q4 | 98.79 | 3.53 | 95.0 | Supplier-supplied | 0 | PASS |
| AX-2025-019441 | Semaglutide | Homopeptide | HOMO-2511-G9197 | 2025-Q4 | 99.93 | 6.87 | — | Supplier-supplied | 2 | FAIL |
| AX-2025-019047 | SS-31 (Elamipretide) | JEEP | JEEP-2511-B3061 | 2025-Q4 | 98.59 | 5.05 | — | Supplier-supplied | 0 | PASS |
| AX-2025-020513 | TB-500 | KP | KP-2510-V5596 | 2025-Q4 | 98.69 | 4.22 | — | Supplier-supplied | 3 | MARGINAL |
| AX-2025-019934 | Mazdutide | SWB | SWB-2505-Y5355 | 2025-Q4 | 98.42 | 3.35 | 97.1 | Supplier-supplied | 1 | FAIL |
| AX-2025-020159 | Liraglutide | GGPeps | GGPE-2505-W9629 | 2025-Q4 | 98.69 | 7.29 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2025-018803 | TB-500 | QSC | QSC-2507-J7717 | 2025-Q4 | 99.88 | 5.60 | 94.6 | Supplier-supplied | 1 | MARGINAL |
| AX-2025-020740 | Afamelanotide | SGN | SGN-2510-R8898 | 2025-Q4 | 98.56 | 5.02 | 101.2 | Supplier-supplied | 1 | MARGINAL |
| AX-2025-020049 | TB-500 | ERP | ERP-2509-K7157 | 2025-Q4 | 99.03 | 1.66 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2025-018601 | GHRP-2 | QYB | QYB-2510-D4955 | 2025-Q4 | 99.36 | 4.05 | 91.5 | Supplier-supplied | 1 | MARGINAL |
| AX-2025-018483 | CJC-1295 with DAC | WWB | WWB-2509-J2816 | 2025-Q4 | 99.08 | 3.57 | 99.5 | Supplier-supplied | 1 | MARGINAL |
| AX-2025-019256 | Selank | TFC | TFC-2511-C6410 | 2025-Q4 | 99.90 | 8.16 | 99.1 | Supplier-supplied | 2 | FAIL |
| AX-2025-020002 | CJC-1295 with DAC | ERP | ERP-2507-A6393 | 2025-Q4 | 99.93 | 4.05 | 103.8 | Supplier-supplied | 1 | MARGINAL |
| AX-2025-018600 | GHRP-2 | QYB | QYB-2510-D4955 | 2025-Q4 | 99.65 | 4.83 | 93.4 | Supplier-supplied | 1 | MARGINAL |
| AX-2025-019335 | Liraglutide | TFC | TFC-2510-C7425 | 2025-Q4 | 99.71 | 4.18 | — | Supplier-supplied | 0 | PASS |
| AX-2025-019178 | AOD-9604 | TFC | TFC-2511-L5476 | 2025-Q4 | 99.93 | 3.02 | 105.3 | Supplier-supplied | 0 | PASS |
| AX-2025-019920 | IGF-1 LR3 | SWB | SWB-2505-N5257 | 2025-Q4 | 97.38 | 6.59 | 102.0 | Supplier-supplied | 0 | PASS |
| AX-2025-018491 | CJC-1295 with DAC | WWB | WWB-2509-J2816 | 2025-Q4 | 99.33 | 3.57 | 90.4 | Supplier-supplied | 1 | MARGINAL |
| AX-2025-019856 | Semaglutide | SWB | SWB-2511-B4697 | 2025-Q4 | 97.93 | 5.40 | 98.5 | Laboratory-retained | 1 | MARGINAL |
| AX-2025-021235 | AOD-9604 | BCH | BCH-2509-K6299 | 2025-Q4 | 98.18 | 4.48 | — | Buyer-sourced | 1 | MARGINAL |
| AX-2025-019020 | N-Acetyl Semax Amide | JEEP | JEEP-2507-U3035 | 2025-Q4 | 99.93 | 8.96 | — | Supplier-supplied | 0 | PASS |
| AX-2025-019574 | Semaglutide | Homopeptide | HOMO-2509-F1941 | 2025-Q4 | 99.62 | 4.85 | 106.2 | Supplier-supplied | 2 | FAIL |
| AX-2025-020780 | Tirzepatide | SGN | SGN-2505-G9671 | 2025-Q4 | 98.72 | 5.84 | 104.6 | Supplier-supplied | 1 | MARGINAL |
| AX-2025-020204 | Enclomiphene citrate | GGPeps | GGPE-2510-H1237 | 2025-Q4 | 99.93 | 5.30 | 94.7 | Supplier-supplied | 2 | FAIL |
| AX-2025-019172 | MK-677 (Ibutamoren mesylate) | TFC | TFC-2511-N5622 | 2025-Q4 | 99.34 | 2.79 | 103.7 | Supplier-supplied | 1 | FAIL |
| AX-2025-019624 | Semaglutide | Homopeptide | HOMO-2505-N2173 | 2025-Q4 | 98.76 | 5.66 | 101.8 | Supplier-supplied | 1 | MARGINAL |
| AX-2025-021133 | Semaglutide | WXT | WXT-2509-A5382 | 2025-Q4 | 98.01 | 6.29 | 104.7 | Supplier-supplied | 1 | MARGINAL |
| AX-2025-020005 | Ipamorelin | ERP | ERP-2505-U6755 | 2025-Q4 | 99.93 | 3.78 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2025-019676 | Tirzepatide | Homopeptide | HOMO-2509-U2115 | 2025-Q4 | 98.04 | 2.44 | 99.8 | Supplier-supplied | 1 | MARGINAL |
| AX-2025-019576 | Semaglutide | Homopeptide | HOMO-2509-F1941 | 2025-Q4 | 99.09 | 4.79 | — | Laboratory-retained | 1 | MARGINAL |
| AX-2025-020090 | ARA-290 | GGPeps | GGPE-2511-F8277 | 2025-Q4 | 99.81 | 2.71 | 103.1 | Supplier-supplied | 0 | PASS |
| AX-2025-020471 | BPC-157 | KP | KP-2511-M5346 | 2025-Q4 | 98.54 | 5.72 | 103.9 | Buyer-sourced | 3 | FAIL |
| AX-2025-020164 | Liraglutide | GGPeps | GGPE-2505-W9629 | 2025-Q4 | 98.59 | 7.57 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2025-019724 | L-Glutathione (reduced) | HJ | HJ-2507-P3062 | 2025-Q4 | 99.14 | 6.97 | 100.8 | Supplier-supplied | 0 | PASS |
| AX-2025-020906 | GHRP-6 | CPC | CPC-2507-G2066 | 2025-Q4 | 99.93 | 6.40 | — | Supplier-supplied | 4 | FAIL |
| AX-2025-019170 | Semaglutide | TFC | TFC-2507-U5442 | 2025-Q4 | 99.93 | 4.17 | — | Supplier-supplied | 0 | PASS |
| AX-2025-019871 | L-Glutathione (reduced) | SWB | SWB-2506-B5296 | 2025-Q4 | 98.69 | 10.27 | — | Supplier-supplied | 2 | MARGINAL |
| AX-2025-019714 | L-Glutathione (reduced) | HJ | HJ-2507-P3062 | 2025-Q4 | 99.09 | 6.62 | — | Supplier-supplied | 0 | PASS |
| AX-2025-019622 | Melanotan II | Homopeptide | HOMO-2508-A1964 | 2025-Q4 | 99.73 | 5.51 | 90.2 | Supplier-supplied | 2 | MARGINAL |